You searched for "protection"
Bevacizumab, NF2, hearing and age
Introduction NF2-related schwannomatosis (NF2-SWN) is an autosomal dominant disorder leading to the development of schwannomas, meningiomas and spinal cord ependymomas. Younger age is a negative prognostic factor. Treatment includes observation, surgery, radiotherapy and medical therapy with bevacizumab (VEGF monoclonal antibody)....Young CEORL-HNS: growing a pan-European ENT network
We are seeing a growth in the number of organisations supporting young ENT surgeons. Young CEORL-HNS is a thriving and expanding group. The Young Confederation of European ORL-HNS (Y-CEORL) was created with a simple idea in mind: to give young...
Artificial intelligence and OSA
The future’s bright, the future’s Orange AI… If you Google ‘how much is AI worth?’, the AI overview tells you “The global artificial intelligence (AI) market size is estimated at approximately $244 billion to $391 billion in 2025 and is...Breakthrough tinnitus device Lenire available in three new clinics in Spain
Neuromod has announced that clinically proven tinnitus treatment device, Lenire, is now available in Malaga, Seville and Granada through partnership with medical technology distributor, TRUSBIN.Evidence-based hospital management of epistaxis
Epistaxis is the most common presentation to acute ENT services in the UK. However, there are currently no nationally accepted guidelines for its management. The British Rhinological Society, ENT UK and INTEGRATE (The National ENT Trainee Research Network) are working...
Do you use the evidence or do you just know to do that?
In this day and age we generally consider healthcare practice to be evidence-based. Unfortunately there are not always the plethora of research articles available that address the dilemmas of day-to-day clinical practice. This piece of work considers what factors influence...Mucormycosis: In conversation with Dr Deepak Haldipur and Dr Aditya Moorthy
COVID-19 has ravaged the world in the past 18 months. The second wave in many countries was deadlier than the first. Mucormycosis, infamously labelled ‘the black fungus’ has affected some countries, such as India, in epidemic proportions within this COVID...The future of treatments for hearing and balance: a 15 and 50-year perspective
Jameel Muzaffar and Manohar Bance paint a picture of what otology will look like 15 and 50 years’ time. Will we still need doctors? Will there still be an ENT news journal? The last 50 years have seen advances including...
We all need to support the human rights of people with communication difficulties
This article starts by reminding us of the Universal Declaration of Human Rights (United Nations, 1948) of which article 19 stated: ‘‘Everyone has the right to freedom of opinion and expression; this right includes freedom to hold opinions without interference...Loss of smell after COVID-19: a view from the patient forums
Patient advocate, Chrissi Kelly, founder of AbScent, talks about how the pandemic has changed the way we think about smell loss. The high prevalence of chemosensory impairment as a result of the SARS-CoV-2 virus has shone a much-needed spotlight on...
Less pain more gain: impact of prophylactic gabapentin on swallowing outcomes in head and neck cancer patients undergoing radiation treatment
Patients planned for chemoradiation to the head and neck are usually advised to expect some pain and soreness during their treatment and that pain relief will be offered as and when it is required. Uncontrolled pain and mucositis affect oral...
